280.00SEK+1.45%Mkt Cap: 843.64M $P/E: 99.29Today
Xvivo Perfusion AB (publ), a medical technology company, develops and markets machines and perfusion solutions for assessing usable organs and maintains in optimal condition pending transplantation in Sweden. It operates…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap843.64M $
Enterprise Value814.05M $
Revenue (TTM)85.63M $
Gross Profit57.34M $
Net Income (TTM)2.41M $
Revenue/Share2.718 USD
Last Price280.00 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees197
CountrySE
SectorHealthcare
IndustryMedical Devices
ISINSE0004840718
Valuation
P/E (Trailing)99.29
P/E (Forward)47.21
PEG—
EV/EBITDA53.77
EV/Revenue9.51
P/S9.82
P/B3.99
EPS (TTM)2.81
EPS (Forward)5.91
52W Range
160.0078% of range314.80
52W High314.80 SEK
52W Low160.00 SEK
Profitability
Gross Margin73.81%
Oper. Margin10.46%
EBITDA Margin17.68%
Profit Margin3.10%
ROE1.19%
ROA1.06%
Growth
Revenue Growth34.00%
Earnings Growth935.10%
Cash Flow & Leverage
Operating CF9.67M $
CapEx (TTM)24.19M $
FCF Margin-3.24%
FCF Yield-0.33%
Net Debt-17.54M $
Net Debt/EBITDA-1.16
Balance Sheet
Debt/Equity0.06
Current Ratio3.86
Quick Ratio2.65
Book Value/Sh69.85 SEK
Cash/Share9.682 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)335.60 SEK
Upside (mean)+19.9%
Target Range300.00 SEK – 385.00 SEK
SEK300.00+19.9% to meanSEK385.00
# Analysts5
Ownership
Shares Out.31.50M
Float25.13M
Insiders8.33%
Institutions59.29%
Technical
SMA 50264.69 (+5.8%)
SMA 200230.47 (+21.5%)
Beta1.46
S&P 52W Chg18.16%
Avg Vol (30d)71.24K
Avg Vol (10d)83.67K
Technical Indicators
RSI (14)52.1
MACD6.8278
MACD Signal6.3011
MACD Hist.+0.5267
BB Upper309.93 SEK
BB Middle270.37 SEK
BB Lower230.81 SEK
BB Width29.26%
ATR (14)11.51 SEK
Vol Ratio (20d)0.81x